Richard Reed – Chairman
Richard Reed was the co-Founder of Innocent Drinks, Europe’s largest and most environmentally sustainable juice company, successfully exited to Coca Cola in 2013 for $600m. Now co-founder of Jam Jar Investments, a consumer goods VC, with early stage investments in category defining companies such as Deliveroo, Blue Bottle Coffee, Graze.com and Tails.com.
Denham Eke – Finance Director
Denham Eke is the Managing Director of Burnbrae Group Limited, a private international asset management company. He began his career in stockbroking with Sheppards & Chase before moving into corporate planning for Hogg Robinson plc, a major multinational insurance broker. He is a director of many years’ standing of both public and private companies involved in the financial services, property, mining, and manufacturing sectors. He is Chairman of Webis Holdings PLC, Co-Chairman of Billing Services Group Limited, and Chief Executive Officer of Manx Financial Group PLC – all quoted on the London AIM market.
Jim Mellon – Non-executive Director
Jim Mellon, based in the Isle of Man, is an author, entrepreneur and an investor with interests in a number of sectors. He has substantial real estate holdings in Germany and the Isle of Man, as well as holdings in private and public companies through his private investment company Burnbrae Group.
After leaving Oxford, where he studied Philosophy, Politics and Economics, he worked in Asia and the United States in two fund management companies, GT Management and Thornton Management (Asia) Limited, before founding Regent Pacific Group Limited in 1991, subsequently quoted on the Hong Kong Stock Exchange.
Mr. Mellon is the co-author of five books, all written with a view to identifying emerging thematic trends leading to investment opportunities. Notably, in his book Wake Up!, he forecast the global financial crisis of ’08-’09. His latest book played a small role in bringing ageing research into the mainstream, and lead to the formation of the company which is co-founder and Chairman, Juvenescence which is a leader in the field.
Mr Mellon is a non-executive director of Condor Gold plc, the executive chairman of the board of Manx Financial Group plc, and the non-executive chairman of the board of SalvaRx Group Plc, all of which are listed on the Alternative Investment Market of the London Stock Exchange. He is also co-founder and Chairman of Regent Pacific Group Limited, (which is listed in Hong Kong), and a non-executive director of Portage Biotech Inc (which is dually listed on the Over the Counter Bulletin Board of NASDAQ of the United States and the Canadian Securities Exchange.
David Giampaolo – Non-executive Director
David Giampaolo is the founder and Chief Executive of Pi Capital. David previously founded, built up and sold several businesses and health club chains in the US and Europe. He has financial interests in several other businesses and industries and has been involved as an investor, advisor and board member of some of the largest and most successful health & fitness companies in the world including Fitness First, 24 Hour Fitness, Zumba Fitness and SARVA (India’s largest chain of yoga, mindfulness and beyond). He is on the board of Coalition for Inclusive Capitalism, Chairman of Gousto and is a senior advisor to AMG (Affiliated Managers Group, Inc.) and BC Partners. David is a member of YPO and CEO global business organisations and a trustee of Speakers4Schools.org and Pro BonoEconomics.
Anderson Whamond – Non-executive Director
Anderson Whamond has over 25 years’ experience in the banking and financial sector. Mr Whamond began his career in 1983 at White Weld Securities (part of the CSFB group) before joining Salomon Brothers International in London in 1986 and then Morgan Stanley International in 1989 where he was a principal in charge of convertible bond trading. He joined Peregrine Securities International (UK) Limited in 1993, relocating to Hong Kong in 1996 to run the equity trading businesses of Peregrine Investment Holdings Limited and became a director of the executive committee of the Peregrine group in 1997. In 1998, he joined the Regent Pacific Group, a Hong Kong listed international emerging markets investment group as head of corporate investments and relocated to the Isle of Man.
Subsequently, he left Regent Pacific Group in August 2000 to pursue his own interests.
Anderson Whamond joined the Charlemagne Group in 2002 and was a director of AIM quoted Charlemagne Capital Limited until March 2009. He remains a director of Charlemagne Capital (IOM) Limited and is also a director of a number of listed and non-listed investment companies.
The audit committee is chaired by Mr Whamond and will also be comprised of Mr Reed and Mr Giampaolo. The audit committee is responsible for providing formal and transparent arrangements for considering how to apply suitable financial reporting and internal control principles having regard to good corporate governance and for monitoring external audit functions including the cost-effectiveness, independence and objectivity of the Company’s auditors.
The Remuneration Committee is chaired by Mr Reed and will also be comprised of the Board.
The Nominations Committee is chaired by Mr Reed and will also be comprised of the Board.
Scientific Advisory Board
The Scientific Advisory Board comprises Ian Smith, Ph.D., Sara Ranjbarvaziri, Ph.D. and Amy Rowat, Ph.D. The three members are highly experienced and seasoned scientists in the fields of cell biology, integrative biology and physiology with strong knowledge surrounding the use of induced pluripotent stem cells (IPSCs). The Scientific Advisory Board assists the Board in making discreet investments within the nascent field of cellular agriculture and synthetic biology.